Apoptosis inhibitor

Details Apoptosis inhibitor Apoptosis inhibitor

2006-10-31

2006-10-31

Fay, Zohreh (Department: 1618)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S573000, C514S912000

Reexamination Certificate

active

07129272

ABSTRACT:
Disclosed is a method for treatment of a subject having a disease or condition associated with apoptosis, which comprises administering to the subject an effective amount of a 15-keto-prostaglandin compound represented by the following formula (I):

REFERENCES:
patent: 5073569 (1991-12-01), Ueno et al.
patent: 5166174 (1992-11-01), Ueno et al.
patent: 5212324 (1993-05-01), Ueno
patent: 5221763 (1993-06-01), Ueno et al.
patent: 5739161 (1998-04-01), Ueno
patent: 6087395 (2000-06-01), Watanabe et al.
patent: 0 308 135 (1989-03-01), None
patent: 0 435 443 (1991-07-01), None
Shahinfar, S. et al., “A pathologic study of photoreceptor cell death in retinal photic injury”, Current Eye Research, vol. 10, No. 1, 1991.
Aoyama-Hayashi, E. et al., PGE1in hibited daunorubicin-induced apoptosis of human leukemia cell line, U937, Japanese Journal of Inflammation, vol. 18, No. 5, Sep. 1998.
Duvall, E. et al., “Death and the cell”, Immunology Today, vol. 7, No. 4, 1986.
Trauth, B. et al., “Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis”, Science, vol. 245, Jul. 21, 1989.
Patent Abstracts of Japan vol. 2000, No. 9, Oct. 13, 2000 & JP 2000 169394 A (Yoshitomi Pharmaceut. Ind. Ltd.).
Patent Abstracts of Japan vol. 1997, No. 2, Feb. 28, 1997 & JP 08 277222A (Green Cross Corp: The) Oct. 22, 1996 abstract.
Feely W. F. Et al., “Normal Phase High Performance Liquid Chromatography of some Prostaglandin B-1 Derivatives” Joruanl of Liquid Chromatography, vol. 12, No. 4, 1989, pp. 515-528, XP000062725 issn: 0148-3919; p. 516, paragraph 2, p. 517.
Katzenschlager R., et al. “Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation” Prostaglandins Leukot Essent Fatty Acids. Mar. 1992, 45(3)L 207-10.

Affiliated with

Also associated with

Rating

Apoptosis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Apoptosis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptosis inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3617473